• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Modulation of spasmogen-stimulated Ins(1,4,5)P3 generation and functional responses by selective inhibitors of types 3 and 4 phosphodiesterase in airways smooth muscle.气道平滑肌中3型和4型磷酸二酯酶选择性抑制剂对痉挛原刺激的肌醇-1,4,5-三磷酸(Ins(1,4,5)P3)生成及功能反应的调节作用
Br J Pharmacol. 1998 May;124(1):47-54. doi: 10.1038/sj.bjp.0701792.
2
Regulation of phosphoinositide turnover in neonatal rat cerebral cortex by group I- and II- selective metabotropic glutamate receptor agonists.I 型和 II 型选择性代谢型谷氨酸受体激动剂对新生大鼠大脑皮层磷酸肌醇代谢的调节
Br J Pharmacol. 1998 Feb;123(3):581-9. doi: 10.1038/sj.bjp.0701626.
3
Modulation of cell adhesion molecule expression and function on human lung microvascular endothelial cells by inhibition of phosphodiesterases 3 and 4.通过抑制磷酸二酯酶3和4对人肺微血管内皮细胞上细胞粘附分子表达和功能的调节
Br J Pharmacol. 1998 May;124(1):229-37. doi: 10.1038/sj.bjp.0701833.
4
Muscarinic receptors in canine colonic circular smooth muscle. II. Signal transduction pathways.犬结肠环形平滑肌中的毒蕈碱受体。II. 信号转导途径。
Mol Pharmacol. 1991 Dec;40(6):952-9.
5
In vitro differentiation of human monocytes to macrophages: change of PDE profile and its relationship to suppression of tumour necrosis factor-alpha release by PDE inhibitors.人单核细胞向巨噬细胞的体外分化:磷酸二酯酶谱的变化及其与磷酸二酯酶抑制剂对肿瘤坏死因子-α释放的抑制作用的关系。
Br J Pharmacol. 1997 May;121(2):221-31. doi: 10.1038/sj.bjp.0701124.
6
Inhibition of histamine-stimulated inositol phospholipid hydrolysis by agents which increase cyclic AMP levels in bovine tracheal smooth muscle.通过增加牛气管平滑肌中环磷酸腺苷水平的药物抑制组胺刺激的肌醇磷脂水解。
Br J Pharmacol. 1989 Jun;97(2):603-13. doi: 10.1111/j.1476-5381.1989.tb11992.x.
7
Control of cyclic AMP levels in primary cultures of human tracheal smooth muscle cells.人气管平滑肌细胞原代培养物中环磷酸腺苷水平的调控
Br J Pharmacol. 1992 Oct;107(2):422-8. doi: 10.1111/j.1476-5381.1992.tb12762.x.
8
Modulation of carbachol-induced inositol phosphate formation in bovine tracheal smooth muscle by cyclic AMP phosphodiesterase inhibitors.环磷酸腺苷磷酸二酯酶抑制剂对牛气管平滑肌中卡巴胆碱诱导的肌醇磷酸生成的调节作用。
Biochem Pharmacol. 1990 Apr 15;39(8):1357-63. doi: 10.1016/0006-2952(90)90013-b.
9
Initial biochemical and functional characterization of cyclic nucleotide phosphodiesterase isozymes in canine colonic smooth muscle.犬结肠平滑肌中环核苷酸磷酸二酯酶同工酶的初步生化及功能特性研究
J Pharmacol Exp Ther. 1993 Feb;264(2):801-12.
10
Lack of effect of zaprinast on methacholine-induced contraction and inositol 1,4,5-trisphosphate accumulation in bovine tracheal smooth muscle.扎普司特对牛气管平滑肌中乙酰甲胆碱诱导的收缩及肌醇1,4,5-三磷酸积累无作用。
Br J Pharmacol. 1991 May;103(1):1119-25. doi: 10.1111/j.1476-5381.1991.tb12310.x.

引用本文的文献

1
Ensifentrine in COPD patients taking long-acting bronchodilators: A pooled post-hoc analysis of the ENHANCE-1/2 studies.恩昔芬净在使用长效支气管扩张剂的慢性阻塞性肺疾病患者中的应用:ENHANCE-1/2研究的汇总事后分析
Chron Respir Dis. 2025 Jan-Dec;22:14799731251314874. doi: 10.1177/14799731251314874.
2
Phosphodiesterase Inhibition as a Therapeutic Strategy for Chronic Obstructive Pulmonary Disease: Where We Have Been and What Lies Ahead.磷酸二酯酶抑制作为慢性阻塞性肺疾病的一种治疗策略:我们的历程与未来方向
Chronic Obstr Pulm Dis. 2025 Jan 29;12(1):82-92. doi: 10.15326/jcopdf.2024.0559.
3
Ensifentrine, a Novel Phosphodiesterase 3 and 4 Inhibitor for the Treatment of Chronic Obstructive Pulmonary Disease: Randomized, Double-Blind, Placebo-controlled, Multicenter Phase III Trials (the ENHANCE Trials).依诺司特,一种新型磷酸二酯酶 3 和 4 抑制剂,用于治疗慢性阻塞性肺疾病:随机、双盲、安慰剂对照、多中心 III 期临床试验(ENHANCE 试验)。
Am J Respir Crit Care Med. 2023 Aug 15;208(4):406-416. doi: 10.1164/rccm.202306-0944OC.
4
Inhaled Phosphodiesterase Inhibitors for the Treatment of Chronic Obstructive Pulmonary Disease.吸入性磷酸二酯酶抑制剂治疗慢性阻塞性肺疾病。
Drugs. 2021 Nov;81(16):1821-1830. doi: 10.1007/s40265-021-01616-9. Epub 2021 Nov 3.
5
Multiple cAMP Phosphodiesterases Act Together to Prevent Premature Oocyte Meiosis and Ovulation.多种环腺苷酸磷酸二酯酶共同作用以防止卵母细胞过早减数分裂和排卵。
Endocrinology. 2018 May 1;159(5):2142-2152. doi: 10.1210/en.2018-00017.
6
Effect of Roflumilast on Airway Blood Flow in COPD: A Pilot Study.罗氟司特对慢性阻塞性肺疾病气道血流的影响:一项初步研究。
Chronic Obstr Pulm Dis. 2017 Aug 28;4(4):262-264. doi: 10.15326/jcopdf.4.4.2017.0151.
7
Novel relaxant effects of RPL554 on guinea pig tracheal smooth muscle contractility.RPL554对豚鼠气管平滑肌收缩性的新型舒张作用。
Br J Pharmacol. 2016 Aug;173(15):2335-51. doi: 10.1111/bph.13512. Epub 2016 Jul 7.
8
Short-term or long-term treatments with a phosphodiesterase-4 (PDE4) inhibitor result in opposing agonist-induced Ca(2+) responses in endothelial cells.用磷酸二酯酶-4(PDE4)抑制剂进行短期或长期治疗会在内皮细胞中引发与激动剂诱导的Ca(2+)反应相反的反应。
Br J Pharmacol. 2008 May;154(1):82-92. doi: 10.1038/bjp.2008.56. Epub 2008 Mar 3.
9
Anti-spasmogenic activity of isoenzyme-selective phosphodiesterase inhibitors in guinea-pig trachealis.豚鼠气管中同工酶选择性磷酸二酯酶抑制剂的抗痉挛活性
Br J Pharmacol. 1999 Sep;128(2):327-36. doi: 10.1038/sj.bjp.0702779.

气道平滑肌中3型和4型磷酸二酯酶选择性抑制剂对痉挛原刺激的肌醇-1,4,5-三磷酸(Ins(1,4,5)P3)生成及功能反应的调节作用

Modulation of spasmogen-stimulated Ins(1,4,5)P3 generation and functional responses by selective inhibitors of types 3 and 4 phosphodiesterase in airways smooth muscle.

作者信息

Challiss R A, Adams D, Mistry R, Nicholson C D

机构信息

Department of Cell Physiology & Pharmacology, University of Leicester.

出版信息

Br J Pharmacol. 1998 May;124(1):47-54. doi: 10.1038/sj.bjp.0701792.

DOI:10.1038/sj.bjp.0701792
PMID:9630342
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC1565354/
Abstract
  1. The effects of isoenzyme-selective inhibitors of phosphodiesterases PDE3 and PDE4 on cyclic AMP concentration, two indices of phosphoinositide hydrolysis, and contractile responses to spasmogens have been investigated in bovine tracheal smooth muscle (BTSM). 2. Neither the PDE3-selective inhibitor ORG 9935, nor the PDE4-selective inhibitor rolipram increased cyclic AMP levels in BTSM. However, rolipram addition in the presence of PDE3 inhibition (ORG 9935; 1 microM) concentration-dependently (-log EC50 (M), 6.55+/-0.15; n = 3) increased cyclic AMP levels to about 70% of the maximal response to the beta-adrenoceptor agonist isoprenaline. 3. Rolipram per se inhibited histamine-stimulated [3H]-inositol (poly)phosphate ([3H]-InsP(X)) accumulation by > 80% (-log EC50 (M), 6.92+/-0.11; n = 3). Although ORG 9935 (1 microM) had little effect on histamine-stimulated [3H]-InsP(X) accumulation alone it greatly facilitated the inhibitory action of rolipram (-log EC50 (M), 8.82+/-0.39; n = 3). The effects of PDE3 and/or PDE4 inhibition on [3H]-InsP(X) accumulation stimulated by muscarinic acetylcholine (mACh) receptor activation were less marked. However, combined PDE3/4 inhibition significantly decreased this response at a submaximal concentration of mACh receptor agonist (carbachol; 1 microM). 4. The greater-than-additive effect of combined PDE3/4 inhibition was also observed at the level of contractile responses to histamine and carbachol. In experiments designed to investigate the effects of PDE3 and/or 4 inhibitors on the carbachol-mediated phasic contraction, additions of rolipram (10 microM) or ORG 9935 (1 microM) were without effect, whereas added together the inhibitors caused a significant (P < 0.01) 40% reduction in the peak phasic contractile response. 5. The effect on contraction correlated with a substantial inhibitory effect of PDE3/4 inhibition on the initial increase in inositol 1,4,5-trisphosphate (InsP3) accumulation stimulated by spasmogen. Thus, in the presence of ORG 9935 (1 microM) rolipram concentration-dependently inhibited carbachol-stimulated InsP3 accumulation by > or = 50% (-log EC50 (M), 6.77+/-0.21; n = 4). 6. Carbachol (100 microM) addition caused a rapid decrease (by 67% at 10 s) in BTSM cyclic AMP level in the presence of PDE3/4 inhibition. However, omission of Ca2+ from the incubation medium prevented the carbachol-evoked decrease in cyclic AMP and this coincided with a greater inhibition (> or = 80%) of the carbachol-stimulated InsP3 response. 7. These data indicate that combined PDE3 and PDE4 inhibition has greater-than-additive effects on second messenger and functional responses to spasmogens in BTSM. Furthermore, the ability of PDE3/4 inhibition significantly to attenuate mACh receptor-mediated contractile responses, may be, at least in part, attributed to an effect exerted at the level of InsP3 generation.
摘要
  1. 已在牛气管平滑肌(BTSM)中研究了磷酸二酯酶PDE3和PDE4的同工酶选择性抑制剂对环磷酸腺苷(cAMP)浓度、磷酸肌醇水解的两个指标以及对致痉剂的收缩反应的影响。2. PDE3选择性抑制剂ORG 9935和PDE4选择性抑制剂咯利普兰均未增加BTSM中的cAMP水平。然而,在存在PDE3抑制作用(ORG 9935;1微摩尔)的情况下添加咯利普兰,浓度依赖性地(-log EC50(M),6.55±0.15;n = 3)将cAMP水平提高至对β-肾上腺素能受体激动剂异丙肾上腺素最大反应的约70%。3. 咯利普兰本身可抑制组胺刺激的[3H]-肌醇(多)磷酸([3H]-InsP(X))积累达80%以上(-log EC50(M),6.92±0.11;n = 3)。虽然ORG 9935(1微摩尔)单独对组胺刺激的[3H]-InsP(X)积累影响很小,但它极大地促进了咯利普兰的抑制作用(-log EC50(M),8.82±0.39;n = 3)。PDE3和/或PDE4抑制对毒蕈碱型乙酰胆碱(mACh)受体激活刺激的[3H]-InsP(X)积累的影响较小。然而,在mACh受体激动剂(卡巴胆碱;1微摩尔)的亚最大浓度下,联合抑制PDE3/4可显著降低这种反应。4. 在对组胺和卡巴胆碱的收缩反应水平上也观察到了联合抑制PDE3/4的超相加效应。在旨在研究PDE3和/或4抑制剂对卡巴胆碱介导的相性收缩影响的实验中,添加咯利普兰(10微摩尔)或ORG 9935(1微摩尔)均无作用,而将抑制剂一起添加可使相性收缩峰值反应显著(P < 0.01)降低40%。5. 对收缩的影响与PDE3/4抑制对致痉剂刺激的肌醇1,4,5-三磷酸(InsP3)积累的初始增加的显著抑制作用相关。因此,在存在ORG 9935(1微摩尔)的情况下,咯利普兰浓度依赖性地抑制卡巴胆碱刺激的InsP3积累达≥50%(-log EC50(M),6.77±0.21;n = 4)。6. 在存在PDE3/4抑制的情况下,添加卡巴胆碱(100微摩尔)可使BTSM中的cAMP水平迅速降低(10秒时降低67%)。然而,从孵育培养基中省略Ca2+可防止卡巴胆碱引起的cAMP降低,这与对卡巴胆碱刺激的InsP3反应的更大抑制(≥80%)同时发生。7. 这些数据表明,联合抑制PDE3和PDE4对BTSM中第二信使和对致痉剂的功能反应具有超相加效应。此外,PDE3/4抑制显著减弱mACh受体介导的收缩反应的能力,可能至少部分归因于在InsP3产生水平上发挥的作用。